ChemicalBook >> CAS DataBase List >>Orantinib (SU6668)

Orantinib (SU6668)

CAS No.
252916-29-3
Chemical Name:
Orantinib (SU6668)
Synonyms
TSU-68;Orantinib;NSC 702827;TSU-68, >=99%;TSU-68 (SU6668);SU 6668(TSU-68);Orantinib (SU6668;Orantinib (TSU-68);TSU-68 (Orantinib,SU6668);TSU-68 (SU6668, Orantinib)
CBNumber:
CB31456201
Molecular Formula:
C18H18N2O3
Molecular Weight:
310.35
MDL Number:
MFCD03426212
MOL File:
252916-29-3.mol
Last updated:2023-09-04 16:42:00

Orantinib (SU6668) Properties

Melting point 252-254 °C
Boiling point 590.5±50.0 °C(Predicted)
Density 1.328±0.06 g/cm3(Predicted)
storage temp. Store at RT
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka 4?+-.0.10(Predicted)
color Orange to Brown
NCI Dictionary of Cancer Terms orantinib
FDA UNII 9RL37ZZ665
NCI Drug Dictionary orantinib

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
GHS05,GHS06,GHS08
Signal word  Danger
Hazard statements  H301-H318-H361-H372
Precautionary statements  P201-P202-P260-P264-P270-P280-P301+P310-P321-P330-P305+P351+P338-P308+P313-P314-P405-P501
NFPA 704
0
3 0

Orantinib (SU6668) price More Price(19)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 13873 SU 6668 ≥98% 252916-29-3 1mg $31 2024-03-01 Buy
Cayman Chemical 13873 SU 6668 ≥98% 252916-29-3 5mg $73 2024-03-01 Buy
Cayman Chemical 13873 SU 6668 ≥98% 252916-29-3 10mg $121 2024-03-01 Buy
Usbiological 022488 TSU-68 252916-29-3 10mg $396 2021-12-16 Buy
TRC T797550 TSU-68 252916-29-3 50mg $425 2021-12-16 Buy
Product number Packaging Price Buy
13873 1mg $31 Buy
13873 5mg $73 Buy
13873 10mg $121 Buy
022488 10mg $396 Buy
T797550 50mg $425 Buy

Orantinib (SU6668) Chemical Properties,Uses,Production

Uses

TSU-68 is a inhibitor that targets vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor β, and fibroblast growth factor receptor 1. The inhibitory effects of TSU-68 towards these growth factors lead to substantial antitumor activity and showed potential in its development in therapeutic uses.

Uses

3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid is a potent inhibitor of Flk-1/KDR, FGFR1 and PDGFRβ with Ki of 2.1 μM, 1.2 μM, and 8 nM, respectively.

Uses

TSU-68 is a inhibitor that targets vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor β, and fibroblast growth factor receptor 1. The inhibitory effects of TSU-68 t owards these growth factors lead to substantial antitumor activity and showed potential in its development in therapeutic uses.

Definition

3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid is an oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is substituted by a 2-(2-carboxyethyl)-3,5-dimethylpyrrol-3-yl group. It is an ATP-competitive inhibitor of the tyrosine kinase activity of fibroblast growth facto receptor 1.

Biological Activity

ATP-competitive PDGFR, VEGF and FGFR inhibitor (IC 50 values are 0.06, 2.43, 3.04 and > 100 μ M at PDGFR β , VEGFR2, FGFR1 and EGFR respectively). Inhibits proliferation of HUVEC and NIH3T3 cells in vitro (IC 50 values are 0.41, 9.3 and 16.5 μ M for VEGF, FGF and PDGF-stimulated growth respectively) and induces > 75% growth inhibition against a broad range of tumor types in vivo . Exhibits antiangiogenic, anti-inflammatory, antimetastatic and proapoptotic activity and is orally active.

in vitro

biochemical kinetic studies using isolated flk-1, fgf receptor 1, and pdgf receptor β kinases revealed that tsu-68 has competitive inhibitory properties with respect to atp. in cellular systems, tsu-68 inhibited receptor tyrosine phosphorylation and mitogenesis after stimulation of cells by appropriate ligands [1].

in vivo

oral or i.p. administration of tsu-68 in athymic mice resulted in significant growth inhibition of a diverse panel of human tumor xenografts of glioma, melanoma, lung, colon, ovarian, and epidermoid origin [1].

storage

Store at RT

References

[1] laird ad, vajkoczy p, shawver lk et al. su6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. cancer res. 2000 aug 1;60(15):4152-60.
[2] okamoto i, yoshioka h, takeda k et al. phase i clinical study of the angiogenesis inhibitor tsu-68 combined with carboplatin and paclitaxel in chemotherapy-naive patients with advanced non-small cell lung cancer. j thorac oncol. 2012 feb;7(2):427-33.

Orantinib (SU6668) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 141)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49390 58
Hebei Lihe Biotechnology Co.,ltd
86-311-80292533 13315122300 sales@lihebiotech.com CHINA 305 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29220 58

View Lastest Price from Orantinib (SU6668) manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid pictures 2019-07-06 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
252916-29-3
US $1.00 / KG 1G 99% 100KG Career Henan Chemical Co

Orantinib (SU6668) Spectrum

3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid TSU-68 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid (Z)-3-(2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid TSU-68 (SU6668) 1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl- SU 6668(TSU-68) (E)-3-(2,4-diMethyl-5-((2-oxoindolin-3-ylidene)Methyl)-1H-pyrrol-3-yl)propanoic acid NSC 702827 TSU-68 (SU6668, Orantinib) Orantinib 3-(2,4-DiMethyl-5-((2-oxoindolin-3-ylidene)Methyl)-1H-pyrrol-3-yl)propanoic acid 5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid TSU-68 (SU6668, Orantinib) TSU-68, >=99% 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid TSU-68 (Z)-3-[2,4-Dimethyl-5-(2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid TSU-68 (SU6668, ORANTINIB);SU 6668;TSU68 Orantinib (SU6668 ORANTINIB (SU6668; TSU-68) Orantinib (TSU-68) TSU-68;SU6668; NSC 702827;TSU 68;TSU68 TSU-68 (Orantinib,SU6668) Orantinib (TSU-68, SU6668) Orantinib (SU6668) USP/EP/BP ORANTINIB;SU6668;SU 6668;NSC 702827 Orantinib SU6668 PDGFR inhibitor ab142156 SU-6668 tsu68 tsu-68 252916-29-3 API Angiogenesis and Metastasis Inhibitors